iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.21 by 57.14 percent. This is a 371.43 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $11.90 million which beat the analyst consensus estimate of $11.63 million by 2.32 percent. This is a 39.25 percent increase over sales of $8.55 million the same period last year.
iRadimed Q4 EPS $0.33 Beats $0.21 Estimate, Sales $11.90M Beat $11.63M Estimate
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.21 by 57.14 percent. This is a 371.43 percent increase over earnings of $0.07 per share from the same
